MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.jvca.2023.07.041

Медицинская библиотека · Journal of cardiothoracic and vascular anesthesia · 2023

Pulmonary Vasodilator and Inodilator Drugs in Cardiac Surgery: A Systematic Review With Bayesian Network Meta-Analysis.

Sardo Salvatore, Tripodi Vincenzo Francesco, Guerzoni Filippo, Musu Mario, Cortegiani Andrea, Finco Gabriele

СтатьяNetwork Meta-AnalysisСистематический обзорПеревод в очереди

Аннотация

OBJECTIVE

The authors performed a systematic review to evaluate the effect of pharmacologic therapy on pulmonary hypertension in the perioperative setting of elective cardiac surgery (PROSPERO CRD42023321041).

DESIGN

Systematic review of randomized controlled trials with a Bayesian network meta-analysis.

SETTING

The authors searched biomedical databases for randomized controlled trials on the perioperative use of inodilators and pulmonary vasodilators in adult cardiac surgery, with in-hospital mortality as the primary outcome and duration of ventilation, length of stay in the intensive care unit, stage 3 acute kidney injury, cardiogenic shock requiring mechanical support, and change in mean pulmonary artery pressure as secondary outcomes.

PARTICIPANTS

Twenty-eight studies randomizing 1,879 patients were included.

INTERVENTIONS: Catecholamines and noncatecholamine inodilators, arterial pulmonary vasodilators, vasodilators, or their combination were considered eligible interventions compared with placebo or standard care.

MEASUREMENTS AND MAIN

RESULTS

Ten studies reported in-hospital mortality and assigned 855 patients to 12 interventions. Only inhaled prostacyclin use was supported by a statistically discernible improvement in mortality, with a number-needed-to-treat estimate of at least 3.3, but a wide credible interval (relative risk 1.26 × 10-17 - 0.7). Inhaled prostacyclin and nitric oxide were associated with a reduction in intensive care unit stay, and none of the included interventions reached a statistically evident difference compared to usual care or placebo in the other secondary clinical outcomes.

CONCLUSIONS

Inhaled prostacyclin was the only pharmacologic intervention whose use is supported by a statistically discernible improvement in mortality in the perioperative cardiac surgery setting as treatment of pulmonary hypertension. However, available evidence has significant limitations, mainly the low number of events and imprecision.

Для цитирования: Sardo Salvatore, Tripodi Vincenzo Francesco, Guerzoni Filippo, Musu Mario, Cortegiani Andrea, Finco Gabriele. Pulmonary Vasodilator and Inodilator Drugs in Cardiac Surgery: A Systematic Review With Bayesian Network Meta-Analysis.. Journal of cardiothoracic and vascular anesthesia. 2023. DOI: 10.1053/j.jvca.2023.07.041.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.